Kazia Therapeutics Limited (United States) is listed on the Nasdaq and has a market capitalization of $57.32 million, with shareholders equity totaling $30.88 million.
The company employs approximately 6 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Kazia Therapeutics Limited reported $1.56 million in revenue, generating net income of $-25.15 million.
Key financial metrics include a P/E ratio of -2.28, a price-to-book (P/B) ratio of 1.86, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker KZIA.